Table 3.
Evaluation of different locations of left ventricular akinesia/hypokinesia in the screening of coronary artery disease
| Anterior wall akinesia/Hypokinesia estimate (95 % CI) | Septal akinesia/Hypokinesia estimate (95 % CI) | Inferior wall akinesia/Hypokinesia estimate (95 % CI) | |
|---|---|---|---|
| Sensitivity (%) | 95.0 (76.4–99.1) | 89.3 (72.8–96.3) | 87.0 (67.9–95.5) |
| Specificity (%) | 33.8 (24.4–44.6) | 34.7 (24.8–46.2) | 32.5 (23.1–43.5) |
| PPV (%) | 26.4 (17.6–37.6) | 34.7 (24.8–46.2) | 27.8 (18.8–39.1) |
| NPV (%) | 96.4 (82.3–99.4) | 89.3 (72.8–96.3) | 89.3 (72.8–96.3) |
| DA (%) | 46.0 (36.6–55.7) | 50.0 (40.4–59.6) | 45.0 (35.6–54.8) |
| LRP | 1.4 (1.4–1.5) | 1.4 (1.3–1.4) | 1.3 (1.2–1.4) |
| LRN | 0.1 (0.01–1.2) | 0.3 (0.1–0.7) | 0.4 (0.2–0.9) |
| DOR | 9.7 (1.2–76.2) | 4.4 (1.2–16.1) | 3.2 (0.9–11.8) |
CI confidence intervals, PPV positive predictive value, NPV negative predictive value, DA diagnostic accuracy, LRP likelihood ratio of a positive test, LRN likelihood ratio of a negative test, DOR diagnostic odds ratio